Identification of Human Liver Cytochrome P-450 3A4 as the Enzyme Responsible for Fentanyl and Sufentanil N-Dealkylation
Authors:
- T. TateishiTTT. Tateishi
- Y. KrivorukYKY. Krivoruk
- Y-F. UengYUY-F. Ueng
- A. J. J. WoodAWA. J. J. Wood
- F. P. GuengerichFGF. P. Guengerich
- M. WoodMWM. Wood
- 1 January 1996
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 82 (1) , 167-172
Abstract
Alfentanil, sufentanil, and fentanyl are synthetic opioids that are metabolized by oxidative N-dealkylation in the liver. We have previously shown that cytochrome P-450 3A4 (CYP3A4) contributes significantly to human liver microsomal alfentanil oxidation. Since identification of specific drug-metabolizing enzymes allows prediction of the variables affecting drug metabolism, the purpose of the present study was to identify the P-450 enzymes responsible for sufentanil and fentanyl metabolism in human liver microsomes. Microsomal preparations fortified with a reduced nicotinamide-adenine dinucleotide phosphate-generating system were incubated with 0.25 micro Meter3 H-fentanyl or3 H-sufentanil. Rates of N-dealkylated metabolite formation significantly correlated with nifedipine oxidation activity (a marker of CYP3A4 activity) for fentanyl and sufentanil (r = 0.93 and 0.87, n = 18, respectively), but not with the oxidation activity for ethoxyresorufin (CYP1A2), S-mephenytoin (CYP2C19), bufuralol (CYP2D6), or chlorzoxazone (CYP2E1). Gestodene and troleandomycin (chemical inhibitors of CYP3A4) and antibody to CYP3A4 inhibited N-dealkylation of fentanyl and sufentanil. Chemical inhibitors of CYP2C, 2E1, and 2D6 did not inhibit N-dealkylation of fentanyl and sufentanil. Recombinant CYP3A4 expressed in Escherichia coli showed N-dealkylation activity of fentanyl and sufentanil, while expressed CYP1A2, 2C10, and 2E1 enzymes did not. We conclude that CYP3A4 is responsible for fentanyl and sufentanil N-dealkylation in vitro. (Anesth Analg 1996;82:167-72)Keywords
This publication has 34 references indexed in Scilit:
- Identification of Cytochrome P450 2E1 as the Predominant Enzyme Catalyzing Human Liver Microsomal Defluorination of Sevoflurane, Isoflurane, and MethoxyfluraneAnesthesiology, 1993
- An Analysis of the Duration of Fentanyl and Its Metabolites in Urine and SalivaAnesthesia & Analgesia, 1993
- Sufentanil DispositionAnesthesiology, 1993
- The P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers, Early Trivial Names of Enzymes, and NomenclatureDNA and Cell Biology, 1993
- Identification of the Pharmacogenetic Determinants of Alfentanil MetabolismAnesthesiology, 1992
- SufentanilDrugs, 1988
- Population Pharmacokinetics of AlfentanilAnesthesiology, 1987
- METHOXYPHENAMINE AND DEXTROMETHORPHAN AS SAFE PROBES FOR DEBRISOQUINE HYDROXYLATION POLYMORPHISMThe Lancet, 1984
- Purification and characterization of six cytochrome P-450 isozymes from human liver microsomesBiochemistry, 1983
- Alfentanil—A Kinetically Predictable Narcotic AnalgesicAnesthesiology, 1982